Answers are grounded in this paper and cite their sources.
Nasopharyngeal carcinoma (NPC) is distinct from other cancers of the head and neck in biology, epidemiology, histology, natural history, and response to treatment. Radiotherapy (RT) is the cornerstone of locoregional treatment of non-disseminated disease and the association of chemotherapy improves the rates of survival. In the case of metastatic disease stages, treatment requires platinum/gemcitabine-based chemotherapy and patients may achieve a long survival time.
No takes yet. Share an insight, caveat, or question.
Rueda‐Domínguez et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: